The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Ongoing impact of tobacco and asbestos on lung cancer mortality
Chinmay Jani, MBBS, Sylvester Comprehensive Cancer Center, Doral, FL, discusses findings from a preliminary study on lung cancer mortality, highlighting that while tobacco-associated mortality has decreased globally, lung cancer deaths in many countries are still linked to tobacco use. There is a pressing need to continue reducing tobacco-related lung cancer rates while also addressing other risk factors, such as air pollution and asbestos. Despite stricter guidelines in the U.S., asbestos-related lung cancer mortality remains twice as high as the global average, underscoring the need for comprehensive health policies targeting multiple risk factors. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
